Predictors of Mortality Among Patients With Head Trauma
NCT ID: NCT06922396
Last Updated: 2025-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
140 participants
OBSERVATIONAL
2024-06-01
2025-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Evaluating the Potential Impact of a Hemorrhagic Risk Stratification Score in Patients With Mild Head Trauma
NCT04993495
Clinical Analysis of Early Hormones Between Patients With Traumatic Brain Injury and Cerebral Hemorrhage
NCT06221215
The Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury
NCT00987688
Management and Outcomes Following Emergency Surgery for Traumatic Brain Injury
NCT04212754
Predicting 28-Day Mortality in Subarachnoid Hemorrhage
NCT06563219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Current estimates suggest that about 4.48 million people lose their lives due to injuries which accounts for 8% of all deaths globally. Of these, an estimated 2 million deaths were attributed to the TBI, and the burden was concentrated in developing countries due to limited access to advanced life-sustaining measures after trauma .
In low-and middle-income countries, head injury patients have worse outcomes than patients in high-income countries . Several studies in Africa have found that death rates from head injury range from 4.2% to 35% .
Evidence suggests that the possible causes for the high mortality rate could be older age, male gender,low GCS, and cause of injuries are likely non-modifiable risk factors and hypoxia, hypotension, hyperthermia, hypo or hyperglycemia, and did not undergo surgery or poor adherence to management guidelines are possible modifiable risk factors .
Clinical presentation of patients and advanced rescue care by emergency teams are crucial factors to determining favorable outcomes. Accordingly, non-surgical management should emphases on rapid transportation, avoiding hypotension and hypoxia, hyperthermia, and medical management to reduce brain edema .
Accurate determination of the prognosis is crucial for the practitioners, in order to optimize and personalize treatment strategies. There is a degree of uncertainty in clinicians' expectations of patient outcomes, and prognostic models can help improve these expectations by providing probabilities of specific outcomes. Compared with the experience of physicians to judge the prognosis of patients, objective prognostic models would be able to give more accurate projections about specific variables such as number of hospitalizations and deaths .
The predictors of mortality modules used are GCS, APACHE II and RTS scores. GCS provides an objective recording of the state of consciousness of a person, which is the only variable referring to brain function in the APACHE II score. APACHE II score was primarily designed to predict mortality in ICUs. The famous models: the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) model and the Corticosteroid Randomization After Significant Head Injury (CRASH) model were weighted towards mixed TBI (moderate and severe TBI).
The management of TBI patients should be followed intracranial pressure monitoring is suggested to reduce post-traumatic death in the hospital within two weeks .
Unfortunately, pre hospital care is not well established and hospitals are not well equipped;this can increase the risk of secondary brain injury due to hypotension and hypoxia .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survivors group
Parameters on admission
A: Parameters on admission:
* Age.
* Sex.
* Comorbidities (DM, HTN, CKD, IHD, Liver Disease)
* Mode of trauma.
* Laboratory data (RBS, INR, AST, ALT, Urea, Creatinine, WBC ,HB, CK, Myoglobin).
* Ct brain findings.
* Scoring system (GCS, RTS, APACHE II).
B: Parameters after 2 weeks:
* Days on Mechanical Ventilation.
* Medical or surgical management.
* Complications (Pneumonia, DVT, septic shock, Pulmonary embolism, ARDS).
Non survivors group
Parameters on admission
A: Parameters on admission:
* Age.
* Sex.
* Comorbidities (DM, HTN, CKD, IHD, Liver Disease)
* Mode of trauma.
* Laboratory data (RBS, INR, AST, ALT, Urea, Creatinine, WBC ,HB, CK, Myoglobin).
* Ct brain findings.
* Scoring system (GCS, RTS, APACHE II).
B: Parameters after 2 weeks:
* Days on Mechanical Ventilation.
* Medical or surgical management.
* Complications (Pneumonia, DVT, septic shock, Pulmonary embolism, ARDS).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Parameters on admission
A: Parameters on admission:
* Age.
* Sex.
* Comorbidities (DM, HTN, CKD, IHD, Liver Disease)
* Mode of trauma.
* Laboratory data (RBS, INR, AST, ALT, Urea, Creatinine, WBC ,HB, CK, Myoglobin).
* Ct brain findings.
* Scoring system (GCS, RTS, APACHE II).
B: Parameters after 2 weeks:
* Days on Mechanical Ventilation.
* Medical or surgical management.
* Complications (Pneumonia, DVT, septic shock, Pulmonary embolism, ARDS).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with GCS=3.
* Patients with associated advanced cervical spine, maxillofacial, severe chest trauma.
* Patients with previous neurological disorders
16 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ayman Mahmoud Alsayes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayman Mahmoud Alsayes
Predictors of Mortality among Patients with Head Trauma
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty Of Medicine , Ain Shams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mortality prediction in TBI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.